中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
8期
59-60
,共2页
阿莫西林%呼吸道感染%应用效果
阿莫西林%呼吸道感染%應用效果
아막서림%호흡도감염%응용효과
Amoxicilin%Respiratory tract infections%Application effect
目的：观察阿莫西林在治疗呼吸道患者中的应用效果。方法：选取2012年1月-2013年3月在本院进行治疗的150例呼吸道感染患者作为研究对象，采用随机对照单盲设计，将其随机分为对照组（洁霉素和病毒唑组）74例和观察组（阿莫西林组）76例，然后比较两组疗效。结果：对照组和观察组的临床总有效率分别为93.40%和87.80%，细菌清除率分别为93.41%和89.10%，两组比较差异均无统计学意义。在用药后症状消失的时间方面，两组间的3个症状比较差异均无统计学意义（P>0.05）。结论：阿莫西林是一种安全有效的治疗呼吸道感染的药物。
目的：觀察阿莫西林在治療呼吸道患者中的應用效果。方法：選取2012年1月-2013年3月在本院進行治療的150例呼吸道感染患者作為研究對象，採用隨機對照單盲設計，將其隨機分為對照組（潔黴素和病毒唑組）74例和觀察組（阿莫西林組）76例，然後比較兩組療效。結果：對照組和觀察組的臨床總有效率分彆為93.40%和87.80%，細菌清除率分彆為93.41%和89.10%，兩組比較差異均無統計學意義。在用藥後癥狀消失的時間方麵，兩組間的3箇癥狀比較差異均無統計學意義（P>0.05）。結論：阿莫西林是一種安全有效的治療呼吸道感染的藥物。
목적：관찰아막서림재치료호흡도환자중적응용효과。방법：선취2012년1월-2013년3월재본원진행치료적150례호흡도감염환자작위연구대상，채용수궤대조단맹설계，장기수궤분위대조조（길매소화병독서조）74례화관찰조（아막서림조）76례，연후비교량조료효。결과：대조조화관찰조적림상총유효솔분별위93.40%화87.80%，세균청제솔분별위93.41%화89.10%，량조비교차이균무통계학의의。재용약후증상소실적시간방면，량조간적3개증상비교차이균무통계학의의（P>0.05）。결론：아막서림시일충안전유효적치료호흡도감염적약물。
Objective:To explore the application effect of amoxicilin in patients with respiratory tract infections. Method:One hundred and fifty patients with respiratory tract infections in the hospital from January 2012 to March 2013 were selected as research object,and they were randomly divided into control group(Lincomycin and ribavirin group)74 cases and observation group(Amoxicilin group)76 cases,then compared the treatment effect of the two groups. This was a single-blind,randomized control trial. Result:The treatment effective rate of the control group and observation group was 93.40%and 87.80%respectively,the bacterial clearance rate was 93.41%and 89.10%respectively,and the difference between the two groups were all no statistically significant(P>0.05). There was no statistically significant difference of three symptoms between the two groups in terms of symptoms disappear time of the medicine. Conclusion:Amoxicilin is effective and safe in the treatment of respiratory tract infection.
